Efficacy and safety analysis of montmorillonite powder combined with bifidobacterium triple viable capsules in the treatment of infantile diarrhea
Objective To analyze the effect of montmorillonite powder combined with bifidobacterium triple viable capsules in the treatment of infantile diarrhea.Methods 94 cases of infantile diarrhea were randomly divided into a control group and an observation group,with 47 cases in each group.The control group was treated with montmorillonite powder,and the observation group was treated with bifidobacterium triple viable capsules based on the control group.The clinical efficacy,symptom improvement time,immune function[immunoglobulin G(IgG),immunoglobulin A(IgA)],and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of 95.74%in the observation group was higher than 82.98%in the control group,and the difference was statistically significant(P＜0.05).After treatment,the improvement time of vomiting,relief time of abdominal pain,recovery time of stool and remission time of fever in the observation group were(1.15±0.34),(1.26±0.23),(2.28±0.87)and(1.12±0.23)d,which were shorter than(2.69±0.65),(2.73±0.51),(4.47±1.13)and(2.54±0.76)d in the control group,and the difference was statistically significant(P＜0.05).Before treatment,there was no significant difference in IgG and IgA between the two groups(P＞0.05).After treatment,the observation group had IgG of(13.78±2.43)g/L and IgA of(1.96±0.43)g/L,which were higher than(10.97±1.87)and(1.32±0.19)g/L in the control group,and the difference was statistically significant(P＜0.05).There was no difference in the incidence of adverse reactions between the observation group and the control group(P＞0.05).Conclusion The combined treatment of montmorillonite powder and bifidobacterium triple viable capsules in children with diarrhea can significantly improve the efficacy,promote the rapid elimination of clinical symptoms,effectively improve the immune function of children,and reduce the occurrence of adverse reactions,which is worthy of clinical promotion and use.
NETL
NSTL
万方数据
维普
